We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Global Healthcare’s Three Big Forecasts: mHealth, Cloud Healthcare, and Regulator Environments

By LabMedica International staff writers
Posted on 09 Dec 2013
Print article
A new market research report, based on a 2013 growth survey, identified major areas of eHealth technology and integration with other businesses.

Frost & Sullivan (Mountain View, CA, USA), an international growth consultancy company, reported in December 2013 its three big predictions for the global healthcare market. Based on a “2013 Search for Growth” survey, which involved 1,835 executives in more than 40 countries worldwide, Frost & Sullivan’s insight highlighted new fields of growth and stated that mHealth (mobile health), the cloud in healthcare, and regulatory environments will be the major themes in 2014 and beyond.

“Frost & Sullivan’s research team has used the findings to select and prioritize the subjects that are deemed to be poised for the greatest growth,” explained Frost & Sullivan partner Dorman Followwill. “The insight has also been essential in unveiling the business outlook for pharmaceuticals, biotechnology, clinical diagnostics, and medical devices, as well as to provide a global perspective on the industry’s geographic hot spots.

mHealth expansion has been fuelled by the unprecedented spread of mobile technologies, as well as further developments in their novel application to address health priorities. It is mostly supported by mobile devices, such as mobile phones, patient monitoring devices, personal digital assistants (PDAs) and other wireless devices. The penetration outlook of mHealth technologies is significant in the following areas: wireless vital signs monitoring, location-aware telemonitoring systems, and Bluetooth wireless technology-enabled health trackers. It is a promising area of opportunity for healthcare growth and it will provide novel systems for participants and for both providers and patients across the spectrum.

Furthermore, as more healthcare information technology (IT) and patient monitoring tools are incorporated, every hospital facility will ultimately have to acquire a fully-enterprise wireless solution. The most innovative mobile healthcare solutions that best meet pressing healthcare needs will be adopted as the gold standard.

Enterprise-wide healthcare informatics will also improve the quality of medical services and efficiency of operations while slashing costs. Cloud computing is considered to be an essential enabler for enterprise-wide systems. Implementing cloud computing technologies correctly will help healthcare providers improve the quality of medical services and the effectiveness of operations, share data across geographic locations, and manage costs. The model can be applied in a range of ways, including data storage and data loss prevention, maintaining patient information records and authorized sharing of information.

The benefits that cloud computing provide can change the dynamics of the healthcare informatics industry over time. The need for efficient sharing of information across locations in a synchronized way will be a key driver for cloud computing in healthcare.

As for regulatory environment, recent healthcare reforms and policy initiatives across many countries have stressed the importance of quality of care more than quantity. In the absence of a sufficient proof of clinical benefit, reimbursements may become a major obstacle.

Overall, three big predictions may be expressed based on the survey’s findings: (1) as healthcare moves towards a customized medicine model, companion diagnostics will change drug development and the marketing process of drug candidates. Combining biomarkers and drugs will result in enhanced therapeutic efficacy and safety. (2) The healthcare and life sciences industry will additionally consolidate in this decade, with many big pharma companies looking for alternatives to the blockbuster model. (3) Lastly, the increase of new technologies capable of integrating medical devices into a connected platform will enhance the functionality of devices, decrease labor burden, and curtail errors.

Other significant areas that have emerged from the same survey include cancer market outlook, remote monitoring, drug delivery market, patient and consumer engagement, eHealth medical records, dashboards, medical devices growth drivers, drug discovery research outsourcing market, homecare market trends, video telemedicine, and cardiovascular therapeutics.

Frost & Sullivan collaborates with clients to utilize recent developments that addresses the global challenges and related growth opportunities that will make or break today’s market participants.

Related Links:

Frost & Sullivan


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.